Kan. Admin. Regs. § 102-3-7b

Current through Register Vol. 43, No. 49, December 5, 2024
Section 102-3-7b - Requirements for board-approved clinical supervisor; application
(a) Each licensee providing postgraduate clinical supervision shall be a board-approved clinical supervisor. This requirement shall apply to each individual commencing a new supervisory relationship on or after July 1, 2017.
(b) In addition to meeting the requirements in K.S.A. 2016 Supp. 65-5818 and amendments thereto and K.A.R. 102-3-7a, the licensee shall successfully complete clinical supervision training, which shall be approved by the board and be specific to providing supervision or becoming a supervisor. This training shall include either 15 hours of continuing education in supervision taken within the last six years or one semester credit hour of a graduate-level course on supervision or the academic equivalent at an accredited college or university approved by the board, each of which shall cover the following material:
(1) Roles in and functions of clinical supervision;
(2) models of clinical supervision;
(3) mental health-related professional development;
(4) methods and techniques in clinical supervision;
(5) supervisory relationship issues;
(6) cultural issues in clinical supervision;
(7) group supervision;
(8) legal and ethical issues in clinical supervision; and
(9) evaluation of supervisee competence and the supervision process.
(c) Each licensee applying for approval as a clinical supervisor shall obtain the appropriate application forms from the board and submit the completed application materials to the board.
(d) To maintain approval as a clinical supervisor, each approved clinical supervisor shall successfully complete the required continuing education specified in K.S.A. 2016 Supp. 65-5818, and amendments thereto.

Kan. Admin. Regs. § 102-3-7b

Authorized by K.S.A. 2016 Supp. 74-7507; implementing K.S.A. 2016 Supp. 65-5818; effective, T-102-5-24-17, May 24, 2017; adopted by Kansas Register Volume 36, No. 38; effective 10/6/2017.